Research / ACA / Fundamental state Inspectable configuration
State dimensions Filing 0001739445-23-000018 General Corporate
Debt relative to revenue 24th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.debt_to_revenue
23.89% · OPTIONAL · VALID
Capex intensity 100th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.capex_revenue_ratio
6.15% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.77% · OPTIONAL · VALID
Revenue growth 38th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
10.14% · CORE · VALID
Inventory pressure 0th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
14.08% · OPTIONAL · VALID
Operating margin 100th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
15.56% · CORE · VALID
SBC intensity 47th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.85% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 28 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 115.35%
Current 23.89%
Delta -91.46% Capex Intensity Increased
Previous 5.46%
Current 6.15%
Delta 0.69% Cash Generation Decreased
Previous 11.82%
Current 7.77%
Delta -4.05% Growth Increased
Previous 8.01%
Current 10.14%
Delta 2.12% Inventory Pressure Decreased
Previous 54.45%
Current 14.08%
Delta -40.37% Profitability Increased
Previous 8.11%
Current 15.56%
Delta 7.45% Sbc Intensity Decreased
Previous 0.89%
Current 0.85%
Delta -0.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.